Bruker unveils MyGenius PRO diagnostics system
The Bruker Microbiology & Infection Diagnostics division has announced the European launch of its MyGenius PRO automated sample-to-answer (S2A) molecular…
The Bruker Microbiology & Infection Diagnostics division has announced the European launch of its MyGenius PRO automated sample-to-answer (S2A) molecular…
Agenus has reported results from a Phase II trial, evaluating the combination of botensilimab (BOT), balstilimab (BAL), and agenT-797 alongside…
Merck & Co (MSD) has received the European Commission (EC) approval for Enflonsia (clesrovimab), indicated to prevent respiratory syncytial virus…
Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Verida system. The device is…
Janux Therapeutics has announced the dosing of its first patient in a Phase I clinical trial evaluating JANX014 for metastatic…
Daiichi Sankyo has signed a research partnership with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor…
Precision BioSciences has received clinical trial application (CTA) approval to expand its global ELIMINATE-B study of PBGENE-HBV, an in vivo…
Boehringer Ingelheim and Zai Lab have entered a clinical collaboration to investigate a dual delta-like ligand 3 (DLL3)-targeting approach for…
GlycoNex has received Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approval to commence a first-in-human Phase I clinical trial of…
US-based Avanos Medical has entered a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an…